- Home
- NBTB vs OCUL Comparison
NBTB vs OCUL Comparison
Compare NBTB & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTB
- OCUL
- Stock Information
- Founded
- NBTB 1856
- OCUL 2006
- Country
- NBTB United States
- OCUL United States
- Employees
- NBTB N/A
- OCUL N/A
- Industry
- NBTB Major Banks
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- NBTB Finance
- OCUL Health Care
- Exchange
- NBTB Nasdaq
- OCUL Nasdaq
- Market Cap
- NBTB 2.3B
- OCUL 2.3B
- IPO Year
- NBTB N/A
- OCUL 2014
- Fundamental
- Price
- NBTB $41.29
- OCUL $11.26
- Analyst Decision
- NBTB Buy
- OCUL Strong Buy
- Analyst Count
- NBTB 3
- OCUL 9
- Target Price
- NBTB $52.33
- OCUL $22.13
- AVG Volume (30 Days)
- NBTB 188.4K
- OCUL 3.2M
- Earning Date
- NBTB 10-27-2025
- OCUL 11-13-2025
- Dividend Yield
- NBTB 3.59%
- OCUL N/A
- EPS Growth
- NBTB 7.37
- OCUL N/A
- EPS
- NBTB 2.77
- OCUL N/A
- Revenue
- NBTB $591,283,000.00
- OCUL $56,664,000.00
- Revenue This Year
- NBTB $26.94
- OCUL N/A
- Revenue Next Year
- NBTB $11.40
- OCUL $18.87
- P/E Ratio
- NBTB $14.88
- OCUL N/A
- Revenue Growth
- NBTB 14.42
- OCUL N/A
- 52 Week Low
- NBTB $37.31
- OCUL $5.79
- 52 Week High
- NBTB $52.44
- OCUL $13.85
- Technical
- Relative Strength Index (RSI)
- NBTB 38.96
- OCUL 41.98
- Support Level
- NBTB $40.90
- OCUL $10.85
- Resistance Level
- NBTB $42.92
- OCUL $11.77
- Average True Range (ATR)
- NBTB 0.87
- OCUL 0.72
- MACD
- NBTB -0.19
- OCUL -0.16
- Stochastic Oscillator
- NBTB 8.91
- OCUL 28.63
About NBTB NBT Bancorp Inc.
NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. Its business, predominantly conducted through NBT Bank, consists of providing commercial banking, retail banking, and wealth management services to customers in its market area, which includes upstate New York, northeastern Pennsylvania, southern New Hampshire, western Massachusetts, Vermont, southern Maine, and central and northwestern Connecticut. The company's reportable segments are Banking and Retirement Plan Administration. A majority of its revenue is generated from the Banking segment.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.